(CIDRAP News) Two biotechnology companiesCrucell, based in the Netherlands, and Integrated BioTherapeutics, based in Germantown, Md.recently announced that they have received $30 million and $22 million contracts, respectively, from the National Institutes of Allergy and Infectious Diseases (NIAID) to develop single vaccines that would protect against both Ebola and Marburg viruses.